BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,127,000 | -47.7% | 16,485 | -50.2% | 0.14% | -55.5% |
| Q3 2020 | $2,154,000 | -36.4% | 33,130 | -28.5% | 0.31% | -44.5% |
| Q2 2020 | $3,387,000 | +45.8% | 46,329 | -32.1% | 0.56% | +18.1% |
| Q1 2020 | $2,323,000 | -17.6% | 68,263 | +31.9% | 0.47% | +35.4% |
| Q4 2019 | $2,818,000 | +82.9% | 51,756 | +40.2% | 0.35% | +56.3% |
| Q3 2019 | $1,541,000 | -21.3% | 36,926 | -17.4% | 0.22% | -17.5% |
| Q2 2019 | $1,957,000 | +42.3% | 44,686 | +67.2% | 0.27% | +32.5% |
| Q1 2019 | $1,375,000 | – | 26,721 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |